Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Plecanatide 0.3 mg	238
Overall Study	STARTED	Plecanatide 1.0 mg	238
Overall Study	STARTED	Plecanatide 3.0 mg	238
Overall Study	STARTED	Placebo	237
Overall Study	COMPLETED	Plecanatide 0.3 mg	189
Overall Study	COMPLETED	Plecanatide 1.0 mg	176
Overall Study	COMPLETED	Plecanatide 3.0 mg	202
Overall Study	COMPLETED	Placebo	171
Overall Study	NOT COMPLETED	Plecanatide 0.3 mg	49
Overall Study	NOT COMPLETED	Plecanatide 1.0 mg	62
Overall Study	NOT COMPLETED	Plecanatide 3.0 mg	36
Overall Study	NOT COMPLETED	Placebo	66

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01429987/flow